anti-cholesterol

  1. M

    Metro Anti-cholesterol drug Praluent lowers risk of death, heart attack – Punch Newspapers

    The anti-cholesterol drug Praluent (alirocumab), made by France’s Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday. Alirocumab was also associated with a 15 percent reduction in death from any cause...
Back
Top